期刊文献+

高表达lncRNAs与肿瘤发生发展的相关性及其临床应用价值 被引量:8

Correlation of high expression long noncoding RNAs with tumor development and its clinical application
下载PDF
导出
摘要 长链非编码RNAs(lncRNAs)为一类长度大于200nt的非编码RNA分子,其可从表观遗传学、转录水平以及转录后水平等3个层面调控基因表达,在许多疾病的发生发展中起重要作用。近年研究发现,lncRNAs在许多肿瘤组织中表达异常,并且其差异性表达与肿瘤的发生、转移和预后相关,提示lncRNAs的表达水平具有潜在的肿瘤诊断、治疗监测和预后评估作用。本文总结了近年来在肿瘤组织中过表达的lncRNAs及其与肿瘤发生、发展的相关性,为正确评价lncRNAs在肿瘤诊断、治疗和预后监测方面的临床应用价值提供科学的理论依据。 Long noncoding RNAs( lncRNAs) is a kind of noncoding RNA molecules with the length more than 200 nt,lncRNAs regulate gene expression through three levels( the epigenetics,transcription and the transcription level),and play an important role in the occurrence and developing of many diseases. Recent studies showed that lncRNAs were aberrantly expressed in many tumor tissues,and their differential expression level were related to tumor metastasis and prognosis. These findings indicated that lncRNAs should be promissing tumor biomarkers for tumor diagnosis,treatment monitoring and prognosis evaluating. In this review,we summarized the studies on the correlation of lncRNAs over expression and tumor development,which will provide the scientific theoretical basis for evaluating the clinical application value of lncRNA as tumor biomarker in cancer diagnosis,treatment and prognosis monitoring.
出处 《现代肿瘤医学》 CAS 2016年第22期3654-3659,共6页 Journal of Modern Oncology
基金 广东省扬帆计划引进拔尖紧缺人才项目(编号:4YF14006G) 广东省科技计划国际合作项目(编号:2013B051000080) 广东省教育厅创新平台特色创新项目(编号:CX14106G) 东莞市科技计划国际合作重点项目(编号:2013508152005) 东莞市社会科技发展重点项目(编号:2014108101055) 广东医学院产学研特色项目(编号:CXY201304)
关键词 长链非编码RNAs 肿瘤 诊断 预后监测 long noncoding RNAs(lncRNAs) tumour diagnosis prognosis monitoring
  • 相关文献

参考文献7

二级参考文献264

  • 1Ming-chun Lai,Zhe Yang,Lin Zhou,Qian-qian Zhu,Hai-yang Xie,Feng Zhang,Li-ming Wu,Lei-ming Chen,Shu-sen Zheng.Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation[J]. Medical Oncology . 2012 (3)
  • 2Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CACancer J Clin 2013; 63: 11-30 [PMID: 23335087 DOI: 10.3322/caac.21166].
  • 3Costello E, Greenhalf W, Neoptolemos JP. New biomarkers andtargets in pancreatic cancer and their application to treatment. NatRev Gastroenterol Hepatol 2012; 9: 435-444 [PMID: 22733351DOI: 10.1038/nrgastro.2012.119].
  • 4Locker GY, Hamilton S, Harris J, Jessup JM, Kemeny N,Macdonald JS, Somerfield MR, Hayes DF, Bast RC. ASCO2006 update of recommendations for the use of tumor markers ingastrointestinal cancer. J Clin Oncol 2006; 24: 5313-5327 [PMID:17060676 DOI: 10.1200/jco.2006.08.2644].
  • 5Simeone DM, Ji B, Banerjee M, Arumugam T, Li D, AndersonMA, Bamberger AM, Greenson J, Brand RE, Ramachandran V,Logsdon CD. CEACAM1, a novel serum biomarker for pancreatic cancer. Pancreas 2007; 34: 436-443 [PMID: 17446843 DOI:10.1097/MPA.0b013e3180333ae3].
  • 6Gold DV, Modrak DE, Ying Z, Cardillo TM, Sharkey RM,Goldenberg DM. New MUC1 serum immunoassay differentiatespancreatic cancer from pancreatitis. J Clin Oncol 2006; 24:252-258 [PMID: 16344318 DOI: 10.1200/jco.2005.02.8282].
  • 7Takayama R, Nakagawa H, Sawaki A, Mizuno N, Kawai H,Tajika M, Yatabe Y, Matsuo K, Uehara R, Ono K, Nakamura Y,Yamao K. Serum tumor antigen REG4 as a diagnostic biomarker inpancreatic ductal adenocarcinoma. J Gastroenterol 2010; 45: 52-59[PMID: 19789838 DOI: 10.1007/s00535-009-0114-y].
  • 8Brand RE, Nolen BM, Zeh HJ, Allen PJ, Eloubeidi MA, GoldbergM, Elton E, Arnoletti JP, Christein JD, Vickers SM, LangmeadCJ, Landsittel DP, Whitcomb DC, Grizzle WE, Lokshin AE.Serum biomarker panels for the detection of pancreatic cancer.Clin Cancer Res 2011; 17: 805-816 [PMID: 21325298 DOI:10.1158/1078-0432.CCR-10-0248].
  • 9He XY, Liu BY, Yao WY, Zhao XJ, Zheng Z, Li JF, Yu BQ, YuanYZ. Serum DJ-1 as a diagnostic marker and prognostic factor forpancreatic cancer. J Dig Dis 2011; 12: 131-137 [PMID: 21401899DOI: 10.1111/j.1751-2980.2011.00488.x].
  • 10Leon SA, Shapiro B, Sklaroff DM, Yaros MJ. Free DNA in theserum of cancer patients and the effect of therapy. Cancer Res1977; 37: 646-650 [PMID: 837366].

共引文献46

同被引文献54

引证文献8

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部